stockrowColgate-Palmolive Company
CL Consumer Defensive Household & Personal Products
Colgate-Palmolive Company’s revenue for fiscal 2025 (year ended December 2025) was $20.4 billion, up 1.40% from fiscal 2024.
- Revenue
- +4.64%
- EPS
- +7.42%
- Free cash flow
- −6.24%
- Total debt
- −8.35%
Quarter to September 2026, against a year earlier
Follow CL
Alert me
Colgate-Palmolive Company (CL) Revenue
Colgate-Palmolive Company's revenue for fiscal 2025 was $20.4B, unchanged from fiscal 2024. Over the twelve months to 30 September 2026 it was $21.3B. Over the past ten years it has ranged from $15.2B (fiscal 2016) to $20.4B (fiscal 2025) — the current reading is the highest in ten years. Revenue has risen for 9 consecutive fiscal years. Colgate-Palmolive Company ranks 3rd of 27 Household & Personal Products companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $20.4B | 1.40% |
| FY2024 | $20.1B | 3.31% |
| FY2023 | $19.5B | 8.29% |
| FY2022 | $18.0B | 3.13% |
| FY2021 | $17.4B | 5.77% |
| FY2020 | $16.5B | 4.96% |
| FY2019 | $15.7B | 0.96% |
| FY2018 | $15.5B | 0.58% |
| FY2017 | $15.5B | 1.70% |
| FY2016 | $15.2B | (5.23%) |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Sep 2026 | $5.4B | 0.15% |
| Jun 2026 | $5.4B | 0.69% |
| Mar 2026 | $5.3B | 1.80% |
| Dec 2025 | $5.2B | 1.93% |
| 43 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| UL Unilever PLC compare | $126.2B |
| PG Procter & Gamble Company (The) compare | $87.9B |
| CL Colgate-Palmolive Company | $21.3B |
| KMB Kimberly-Clark Corporation compare | $16.6B |
| EL The Estee Lauder Companies Inc. compare | $15.3B |
| CLX The Clorox Company compare | $7.2B |
| CHD Church & Dwight Co., Inc. compare | $6.2B |
| ELF e.l.f. Beauty compare | $1.9B |
| IPAR Interparfums, Inc. compare | $1.5B |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on CL
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement